The first steps in cell line development are the key for the success of the whole project

UGA Biopharma is a Germany-based, full contract service R&D provider in the field of mammalian cell line development. UGA`s proven core expertise is the development of cell lines for biosimilar and biotherapeutic manufacturing. The UGA offering includes:


  • Cell line development of research cell banks for pharmaceutical manufacturing (different CHO host cell lines available)
  • Upstream process development (USP) and downstream process development (DSP)
  • Contract analytical service
  • Tech transfer and process implementation consulting
  • Training in cell line development and culture techniques


  • Ready-to-use research cell banks for biosimilar manufacturing including fermentation, DSP and analytical-method protocols
  • Cost-effective and GMP-compliant cell-culture basal media for high yields (chemically defined, suitable for biopharma production) - free test sample available; feed A and B in development, launch expected in Q3/2017
  • CHO mock cell lines available for out-licensing


MARCH 2017: Launch of UGA´s "high-speed workflow"
UGA has launched an improved cell-line-development workflow ("high-speed workflow"), which guarantees cell line development on a shortened time more

APRIL 2017: Opening of additional development labs at UGA Biopharma
UGA Biopharma will open additional laboratories featuring state-of-the-art equipment at the Hennigsdorf site for cell line development and analytical contract services. The extension is tailor-made more

UGA Biopharma presented at BIONNALE 2017
Pitch presentation "Cell lines for biosimilar and NBE manufacturing + services" more

Contact us!

UGA Biopharma GmbH
16761 Hennigsdorf, Neuendorfstraße 20a (Germany)
E-Mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Phone: +49 (0)3302 / 2024900

We call you back

Leave your name and phone number, we will call you back immediately